Quick answer
Arrowhead Pharmaceuticals, Inc. (ARWR) reported revenue of $829.4M and net loss of $1.6M for the fiscal year ended 2025-09-30, up 23258.2% from $3.6M the year before, per its 10-K filed with the SEC on 2025-11-25.
Data as of 2025-09-30. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Fiscal year | Revenue | Net income | Long-term debt |
|---|---|---|---|
| 2025 (FY ending 2025-09-30) | $829.4M | -$1.6M | — |
| 2024 (FY ending 2024-09-30) | $3.6M | -$599.5M | — |
| 2023 (FY ending 2023-09-30) | $240.7M | -$205.3M | — |
| 2022 (FY ending 2022-09-30) | $243.2M | -$176.1M | — |
| 2021 (FY ending 2021-09-30) | $138.3M | -$140.8M | — |
| 2020 (FY ending 2020-09-30) | $88.0M | -$84.6M | — |
| 2019 (FY ending 2019-09-30) | $168.8M | $68.0M | — |
| 2018 (FY ending 2018-09-30) | $16.1M | -$54.5M | — |
| 2017 (FY ending 2017-09-30) | $31.4M | -$34.4M | — |
| 2016 (FY ending 2016-09-30) | $0.2M | -$81.7M | — |
Related
- ARES revenue, net income and debt history (Ares Management Corporation)
- ARMK revenue, net income and debt history (Aramark)
- ARW revenue, net income and debt history (Arrow Electronics, Inc.)
- ASTS revenue, net income and debt history (Ast Spacemobile, Inc.)
- ATI revenue, net income and debt history (ATI Inc.)
- ATO revenue, net income and debt history (Atmos Energy Corp)
- AUR revenue, net income and debt history (Aurora Innovation, Inc.)
- AVT revenue, net income and debt history (Avnet, Inc.)
Last updated 2026-10-16. Data only, not financial or tax advice.